These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3492692)

  • 21. Induction of chromosomal beta-lactamases by different concentrations of clavulanic acid in combination with ticarcillin.
    Stobberingh EE
    J Antimicrob Chemother; 1988 Jan; 21(1):9-16. PubMed ID: 3128523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity in vitro of ticarcillin and ticarcillin plus clavulanic acid against Enterobacteriaceae, Pseudomonas aeruginosa and Acinetobacter calcoaceticus.
    Campos P; Vera A; Martin-Luengo F
    Chemioterapia; 1987 Jun; 6(2 Suppl):77-8. PubMed ID: 3151358
    [No Abstract]   [Full Text] [Related]  

  • 23. Timentin (ticarcillin/clavulanic acid): lack of antagonism in an in vitro kinetic model, against bacteria producing inducible class-1 beta-lactamase.
    Slocombe B; Cooper CE; Masters PJ; Warrack JD
    J Chemother; 1989 Jul; 1(4 Suppl):353-4. PubMed ID: 16312436
    [No Abstract]   [Full Text] [Related]  

  • 24. Comparative in vitro susceptibilities of 504 bacteremic isolates to ticarcillin plus clavulanic acid and other antimicrobial agents.
    Rotstein C; Amsterdam D; Beam T; Gorzynski E
    Diagn Microbiol Infect Dis; 1989; 12(2):157-63. PubMed ID: 2752713
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clavulanic acid/antibiotic ratios.
    Rolinson GN
    J Antimicrob Chemother; 1985 Feb; 15(2):256-7. PubMed ID: 3980316
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro susceptibility of bacteria to a ticarcillin-clavulanic acid combination.
    Sparks SE; Jones RL; Kilgore WR
    Am J Vet Res; 1988 Dec; 49(12):2038-40. PubMed ID: 3239838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Timentin resistance.
    Masterton RG; Garner PJ; Harrison NA; Rainford DJ
    Lancet; 1987 Oct; 2(8565):975-6. PubMed ID: 2889900
    [No Abstract]   [Full Text] [Related]  

  • 28. The pharmacology of clavulanic acid and ticarcillin combined.
    Scully BE; Steinman R; Chin NX; Neu HC
    Chemioterapia; 1984 Dec; 3(6):385-9. PubMed ID: 6529781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid.
    Fuchs PC; Jones RN; Barry AL; Thornsberry C
    J Clin Microbiol; 1984 Apr; 19(4):555-7. PubMed ID: 6715524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Susceptibility of ticarcillin-resistant gram-negative bacilli to different combinations of ticarcillin and clavulanic acid.
    Verbist L; Verhaegen J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():7-15. PubMed ID: 3636338
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Susceptibility testing recommendations for ticarcillin/clavulanic acid in the Stokes' disc diffusion test.
    Sutherland R
    J Antimicrob Chemother; 1989 Sep; 24(3):463-4. PubMed ID: 2808198
    [No Abstract]   [Full Text] [Related]  

  • 32. In-vitro bacterial killing kinetics of ticarcillin/clavulanic acid.
    Gould IM; Dent J; Wise R
    J Antimicrob Chemother; 1987 Mar; 19(3):307-12. PubMed ID: 3106304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Activity of ticarcillin combined with different concentrations of clavulanic acid on 137 Gram-negative bacilli resistant to ticarcillin].
    Aubert G; Dorche G; Frere A; Raby N; Denis M
    Pathol Biol (Paris); 1987 May; 35(5):537-41. PubMed ID: 3302858
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.
    Casey P; Glauser M
    Eur J Clin Microbiol; 1983 Dec; 2(6):541-7. PubMed ID: 6607834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Timentin and beta-lactamases.
    Labia R; Morand A; Péduzzi J
    J Antimicrob Chemother; 1986 May; 17 Suppl C():17-26. PubMed ID: 3487538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: a multicenter study.
    Fuchs PC; Jones RN; Barry AL; Allen SD; Aldridge KE; Gerlach EH; Sommers HM
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):47-50. PubMed ID: 3370931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity of ticarcillin in the presence of clavulanate potassium.
    Sutherland R; Beale AS; Boon RJ; Griffin KE; Slocombe B; Stokes DH; White AR
    Am J Med; 1985 Nov; 79(5B):13-24. PubMed ID: 3878080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chemical structure, anti-bacterial activity and pharmacokinetics of penicillins].
    Miyashita T; Ono Y; Kunii O
    Nihon Rinsho; 1991 Oct; 49(10):2266-70. PubMed ID: 1660944
    [No Abstract]   [Full Text] [Related]  

  • 40. Ticarcillin--clavulanic acid (Timentin).
    Med Lett Drugs Ther; 1985 Aug; 27(694):69-70. PubMed ID: 3894901
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.